Jasmin David from south Manchester, England, has been miraculously cleared of cancer after using an experimental drug.
Doctors said she only had less than a year to live after the cancer spread to her lungs, lymph nodes, and chest bone.
David is a mother of two who worked in a care home for the elderly. In 2017, she became suspicious after noticing a lump above her nipple. Later in November, David discovered she had an aggressive triple-negative form of breast cancer.
In 2018, she underwent six grueling months of chemotherapy and a mastectomy, followed by 15 cycles of radiotherapy, which successfully cleared her body of cancer.
Unfortunately, the cancer returned in October 2019. A scan showed multiple lesions throughout her body leading to a poor prognosis. David made the decision two months later to take part in a clinical trial at The Christie. She was given an experimental drug combined with Atezolizumab, an immunotherapy drug never used in humans before. Doctors have told her she is now showing no evidence of the disease.
“At first I had many horrible side effects including headaches and spiking temperatures, so I was in hospital over Christmas and quite poorly,” David told the Granada Reports. “Then thankfully I started to respond well to the treatment.”
“Two and a half years ago I thought it was the end and I now feel like I’ve been reborn.”
“I have decided to take early retirement and to live my life in gratitude to God and to medical science. My family have been very supportive of this decision. I will be celebrating my 25th wedding anniversary in September. I have so much to look forward to,” she added.
David will continue her treatment in the clinical trial until December 2023.
Professor Fiona Thistlethwaite, medical oncologist and clinical director of Manchester CRF at The Christie, who leads the study, said, “We are really pleased that Jasmin has had such a good outcome.”
